Primobolan

weak data

Also seen as: Methenolone, Metenolone, Primo, Methenolone Enanthate

The Dose Guy’s verdict
Sep 1, 2026
2 sources

Primobolan is the most overpaid compound on this shelf. Real but unspectacular gains, a mild side profile, and a price tag built on decades of bodybuilding mythology. Worse, it is faked more than almost anything on this shelf: what arrives in the vial is often a cheaper compound with a primobolan label. The clinical data is old, sparse, and has nothing to do with physique. If you can afford the real compound and verify it, it is a genuinely mild option. That is a lot of ifs.

Would I take it?Caution, you're paying for a reputation.

What it is

Primobolan is a DHT-derived steroid, methenolone, with an added 1-methyl group that helps the oral form survive the liver somewhat better than most orals, though the injectable enanthate is still what people actually run. It does not aromatize to estrogen, produces no water retention, and is weakly androgenic, which is why it earned the mild tag. The trade-off for mild is modest: primobolan adds lean tissue slowly and in small amounts relative to what testosterone or nandrolone delivers at comparable doses. You are paying more per milligram for less effect per milligram.

The counterfeiting problem deserves its own sentence. Primobolan is expensive to produce relative to other anabolics, and the demand is high because of the reputation. Underground labs routinely substitute masteron or low-dose testosterone and sell it as primobolan. Without a third-party COA, you do not know what you have, and most people who think they ran primobolan never did.

What the research shows

The published data is old, clinical, and not about physique. No trial has tested primobolan for muscle gain, fat loss, or athletic performance:

Among 41 evaluable patients with disseminated or inoperable breast carcinoma, 8 had objective remissions lasting longer than three months during methenolone enanthate treatment at 400 to 1,200 mg weekly. Investigators judged methenolone less virilizing than testosterone propionate.Acta Oncol 1975 · therapeutic study · n=43
During methenolone enanthate treatment in 28 menopausal women with metastatic breast carcinoma, 10 developed type IIa hyperlipoproteinemia and 2 developed type IIb. All cases regressed after discontinuation.Dtsch Med Wochenschr 1981 · n=28
No randomized human trial of methenolone for body composition, strength, or performance exists.as of Aug 2026

Realistic protocols

If you have verified real primobolan in hand, the community runs it as a mild lean-gainer alongside a testosterone base, or as a cutting compound where the goal is preserving muscle while the deficit does the work. It does not aromatize, so estrogen management is simpler.

The doses run higher than most injectables because the effect per milligram is lower. This is where the price really bites: running primobolan at 400 to 600 mg a week costs more than a comparable run of testosterone or boldenone. The oral form exists and avoids the needle, but the bioavailability is low enough that the doses needed make it impractical for most people.

Cycles run 12 to 16 weeks because the effect builds slowly. PCT is simpler than the 19-nors: standard recovery applies, and primobolan clears without the metabolite tail that makes nandrolone recovery slow.

Bloodwork before, during, and after: lipids, hematocrit, estrogen. The lipid shifts are real even on a compound with a mild reputation, and running it at the doses required makes monitoring non-negotiable.

For a similar profile at a fraction of the cost, masteron delivers the same dry, non-aromatizing look. The premium on primobolan is real, and it buys you a mild compound that most people are not actually getting.

Lean bulk400–600 mg/wkEnanthate, twice weekly. Lower doses are not worth the cost.
Cutting300–400 mg/wkMuscle preservation on a deficit. Where primo earns its keep, if real.
Test baseTRT to equalTestosterone alongside, always. Primo is not a standalone.
Cycle length12–16 weeksIt needs time to show. Short runs are wasted.

Side effects

Mild by design, which is both the selling point and the limit:

commonHair thinning in those predisposed. DHT-derived, so the same risk as masteron, just less aggressive because the compound is milder overall.
monitorLipid shifts. The breast cancer trial found hyperlipoproteinemia in 12 of 28 patients at doses that overlap with what the community runs. All cases reversed after stopping. Bloodwork matters.
commonSuppression of natural testosterone production. Milder than nandrolone or trenbolone, but still complete at cycle doses. PCT is required.
anecdotalInjection site discomfort with enanthate, reported as a mild burn or irritation. Not universal.

Where to buy

$10.20 / 100mg vial$0.10/mg
✓ verified Sep 12

Prices move. Links are affiliate links; they never change a ranking, and scores are set before the deal exists.